Project Grant R41AI157347
Award Date
7/6/21
Completion Date
6/30/22
Dollars Obligated
$788K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Fort Collins, CO, USA
Similar Awards
The National Science Foundation awarded the University of Illinois a $100,000 project grant under the NSF Technology, Innovation, and Partnerships program to develop an aerial virus detector system. The university will use the one-year award ending June 2023 to create a portable device that can directly detect airborne COVID-19 and other viral particles. The proposed technology integrates a COVID-reactive surface with a sensitive detection mechanism to identify the presence of a virus particle...
This $229,454 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to develop a fluorescence-based experimental apparatus capable of in situ measurements of the phase state, viscosity, and pH of size-resolved fine and ultrafine respiratory and drug aerosol particles. The key objectives are to: 1) develop the fluorescence apparatus and establish the basis for measuring the phase state, viscosity,...
This Project Grant award of $760,500 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to address critical limitations in studying the transmission of airborne pathogens. The University of Texas at Dallas (UTD) will design and build a bioaerosol generation system to produce monodisperse (uniform size) pathogen-laden bioaerosols in sufficient quantities to detect live pathogens and...
This Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $150,000 to the University of Illinois to develop proactive solutions for public health protection against airborne diseases. The key objectives are: Create an intelligent, automated system for real-time, multiplex monitoring of critical airborne pathogens, including the ability to obtain time-resolved measurements of infectious aerosols...
This $2,074,701 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a multidisciplinary research initiative to investigate the biological and physical drivers of influenza A virus (IAV) transmission in humans. The project aims to leverage a controlled human infection model to obtain high-resolution data on viral load dynamics, immune responses, and infectious aerosol...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,473,521.00 in funding to the Scripps Research Institute in La Jolla, California. The grant supports the development of a novel therapeutic approach to inhibit SARS-CoV-2 infection and COVID-19 disease. The proposed strategy involves delivering a tailored RNA encoding the diphtheria toxin fragment A (COV-2...
This $255,870 National Science Foundation Technology, Innovation, and Partnerships grant to Strivision LLC supports the development of an airborne contagion mapping platform through visual exhale monitoring. The goal is to create a method for monitoring and evaluating exposure risks from airborne viral contaminants such as COVID-19 to reduce public health risks from respiratory disease transmission. Strivision will advance understanding of how airborne contagions spread within indoor spaces by...
This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...
The National Science Foundation (NSF) awarded a $650,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of California, Los Angeles (UCLA) to develop a suite of portable, quantum-enhanced sensors for detecting and identifying bioaerosols. The project aims to advance the technology readiness level of sensor technologies targeting bioaerosols, which directly impact human, animal, plant, and climate health. The key products to be...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $297,761 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Biological Mimetics, Inc. to develop a sensitive, rapid, and affordable CRISPR-based diagnostic test for malaria parasites. The project aims to create an instrument-free, simple-to-run diagnostic that requires no advanced training and is suitable for resource-limited regions. Key objectives include optimizing the isothermal amplification...